Classic Biotech & Exports (Delisted) financials and balance sheet

BSE: 531670

Last traded ₹6.18 on 28 Dec 2007

Delisted on 1 Dec 2017.

1 year at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2008

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue0.9
  2. Depreciation−0.3
  3. One-off items−0.3
  4. Profit before tax−0.7
  5. Net profit−0.7

Profit and loss

Standalone, ₹ crore, years to March.Classic Biotech & Exports quarterly results

₹ croreMar 2008
Revenue from operations0.90
–
Materials and goods bought0.57
Depreciation and amortisation0.27
One-off items−0.32
Profit before tax−0.66
Net profit−0.66
Net margin−73.4%
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2008: the statement does not state its finance costs, which operating profit is worked out from, so operating profit is not given.